Skip to main content

Interference of the new oral anticoagulant dabigatran with frequently used coagulation tests.

Halbmayer WM, Weigel G, Quehenberger P, Tomasits J, Haushofer AC, Aspoeck G, Loacker L, Schnapka-Koepf M, Goebel G, Griesmacher A

Publication: Clin Chem Lab Med (2012) • Vol 50 • Page 1601-5PMID: 23100377View on PubMed

Purpose

The purpose of this paper was to determine the effects of the oral anticoagulant dabigatran on routine coagulation assays using spiked plasma.

Conclusion

The oral anticoagulant dabigatran interfered with routine coagulation assays when spiked plasma was tested, however, thrombin-independent assays were generally less affected by dabigatran.

Studies (1)

Purpose

The purpose of this study was to determine the effects of the oral anticoagulant dabigatran on routine coagulation assays using spiked plasma. Data was pooled from six hospitals which used different reagents and analyzers for each of the assays.

Summary of Findings

The addition of dabigatran to plasma specimens led to dose dependent decreases in the percentage of PT activity, increases in APTT, and increases in AT activity via factor IIa. The authors report that results were highly variable between hospitals, likely due to the different reagents used. When fibrinogen assays were performed with reagents containing >50 units/mL thrombin, dabigatran had less effects, but reagents with a lower thrombin concentration yielded decreased fibrinogen concentration measurements when dabigatran levels were >0.24 ug/mL. Plasma specimens spiked with dabigatran also showed decreases in clotting factor activities and false positive diagnoses of lupus anticoagulant and APC-resistance. Thrombin-independent assays (von Willebrand-factor antigen, free Protein S, plasminogen, protein C, and AT via Xa) were generally less affected or were not affected by dabigatran.

  • Biospecimens

    FluidPlasma
  • Preservation Types

    Other Preservative
  • Diagnoses

    Normal
  • Platforms

    ProteinHematology/ auto analyzer
    GlycoproteinHematology/ auto analyzer
    MorphologyHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBiospecimen components
    0.00 ug/mL dabigatran
    0.05 ug/mL dabigatran
    0.10 ug/mL dabigatran
    0.24 ug/mL dabigatran
    0.48 ug/mL dabigatran
    Hematology/ auto analyzer SpecificReaction solution
    <50 U/mL thrombin
    >50 U/mL thrombin